Nuway Distributors, LLC. is issuing a voluntary recalls of all lots of its APEXXX tablets that were distributed and sold at the consumer level, according to the U.S. Food and Drug Administration (FDA).
After the U.S. Food and Drug Administration (FDA) conducted tests and confirmed the presence of Slidenafil in the APEXX tablets, Nuway Distributors issued a voluntary recall of the product.
The recalled APEXXX products are packaged individually and contain the UPC code 705105963617. All lots of APEXXX are included in this recall and were sold in 2014 through June 2015 at retail stores in the Orlando area.
APEXXX can be identified by its black packaging and yellow diamond shaped tablet.
Slidenafil, which is the undeclared additive in the recalled products, may pose a threat to consumers because Slidenafil has the potential to react with other prescription drugs that contain nitrates, which could lower blood pressure to dangerous and potentially life threatening levels.
Consumers that have heart disease, high blood pressure, high cholesterol, and diabetes often take prescription medications which contain nitrates.
As well as reacting to nitrates, Slidenafil may also cause other side effects such as headaches and flushing.
Nuway Distributors is also voluntarily recalling all lots of OPAL tablets at the consumer level since they were manufactured from the same source as the APEXXX tablets.
OPAL tablets can be identified by their black packaging and black diamond shaped tablet. OPAL tablets were also sold in the Orlando area.
Nuway Distributors recommends that users stop using the products immediately and make arrangements for their return and to contact their primary health care provider if they are experiencing any of the symptoms listed above.